REVEALED: Ibrx - The Real Truth

Why 2 Small Biotechs May Hold the Key to New Cancer Treatments

Iovance and ImmunityBio have doubled and quadrupled in share price so far this year, respectively, thanks to powerful cancer medicines that could upend care.

MarketBeat · Mar 12

Biotech Breakouts: 3 Stocks With Massive Upside Potential

Biotech stocks are highly volatile; however, these biotech stocks have key trial results this fall that could spark sharp moves and long-term growth potential

MarketBeat · Sep 17, 2025

ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting

ImmunityBio Inc (NASDAQ: IBRX) 

Benzinga · Feb 15, 2022